中国僵尸片,亚洲欧美国产另类视频,亚洲精品无码人妻无码,亚洲有码转帖,亚洲欧美精品伊人久久,97精品依人久久久

該職位已失效,看看其他機(jī)會(huì)吧

醫(yī)學(xué)事務(wù)解決方案副經(jīng)理-北京

2-3.5萬(wàn)
  • 北京東城區(qū)
  • 1-3年
  • 碩士
  • 全職
  • 招1人

雇員點(diǎn)評(píng)標(biāo)簽

  • 同事很nice
  • 團(tuán)隊(duì)執(zhí)行強(qiáng)
  • 工作環(huán)境好
  • 人際關(guān)系好
  • 氛圍活躍
  • 實(shí)力大公司

職位描述

藥企
Job Description The Medical Solution Manager is responsible for providing cost effective and innovative solutions to the development and needs of China Medical team in different areas, through engagement with a broader range of internal and external stakeholders, led by Pfizer and China Medical values. The RWE and Study role of Associate Medical Solution Manager, will identify and prioritize RWE gaps, advise innovative RWE projects for different Categories; also as a statistics professional to supervise and provide statistical inputs or consultation to data management and statistical analyses for Pfizer sponsored or cooperative studies (such as NIS or RWS); and will be the facilitator to manage Pfizer sponsored post approval studies (nonregistration purposes) & Research Collaborations through coordination and cooperation with related internal and external stakeholders. All the above duties will be carried out under the guidance of China Medical Excellence/Operations Lead. Real World Evidence: ● Interact with stakeholders to identify and prioritize data gaps and align with local Category teams and global RWE team on appropriate strategies and methods to meet those gaps. ● Identify and evaluate existing external databases and research partners for potential collaboration on RWE projects. ● Accountable as project consultant for coordination of design, planning and delivery of innovative RWE programs. ● Provide RWE-related academic support to internal and external stakeholders by coordinating multiple resources. Statistics: ● From statistical perspectives to advise China Medical team on study design, data management, statistical analysis, interpretation of statistical results, and publications. ● Interact with third parties to supervise and provide statistical inputs to data management and statistical analyses and ensure timeliness and quality of statistical deliverables according to agreement in Pfizer sponsored post approval studies. ● Assistance with the development of statistics-related training courses led by ME&O team. Study Management: ● Establishes the close cross-functional collaboration of all components of a study by working with study team members (including but not limited to Medical Advisors, Study Project Managers, Study Managers, Data Managers, Clinical Programmers, Medical Writers and Project Planners, Safety, Statisticians, Compliance Oversight, Regulatory and Medical QA) both internal and external to Pfizer to ensure studies deliverables. ● Develops working model for study (NIS or Research Collaborations) operation function in China Medical. Overall management on progress, quality, timeline, and budget to ensure all studies conducting smoothly and in accordance with SOP and good quality through leading the team in managing issues and driving for continuous improvement. ● Responsible for overall CRO management and site management to ensure study complied with GCP, SOP, company policy and regulations. ● Responsible for the development and ongoing management of contract and budget internally and externally. ● Creates effective, accurate and timely communication of project progress and issues to local and global leadership. Guides local team in escalation pathways to ensure the issues resolving timely. ● Responsible for PCO, CCR, FCPA, and MQC review to ensure good compliance results. Leads the related trainings for Pfizer colleagues and CRO to ensure compliance. Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates. Medical #LI-PFE
查看全部

工作地點(diǎn)

北京東城區(qū)五礦廣場(chǎng)-B座

職位發(fā)布者

劉一飛/人事經(jīng)理

昨日活躍
立即溝通
公司Logo輝瑞投資有限公司公司標(biāo)簽
輝瑞公司(Pfizer Inc.)創(chuàng)建于1849年,總部位于美國(guó)紐約,是一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。輝瑞的使命是“為患者帶來(lái)改變其生活的突破創(chuàng)新”。在輝瑞,我們通過(guò)科學(xué)和全球資源為人們提供治療方案,以延長(zhǎng)其生命,顯著改善其生活。在醫(yī)療衛(wèi)生產(chǎn)品的探索、研發(fā)和生產(chǎn)過(guò)程中,輝瑞始終致力于奉行嚴(yán)格的質(zhì)量、安全和價(jià)值標(biāo)準(zhǔn)。我們?cè)谌虻漠a(chǎn)品組合包括創(chuàng)新藥品和疫苗。每天,輝瑞在發(fā)達(dá)和新興市場(chǎng)的員工都在推進(jìn)人類健康,推動(dòng)疾病的預(yù)防、治療和治愈,以應(yīng)對(duì)挑戰(zhàn)我們這個(gè)時(shí)代的頑疾。輝瑞還與醫(yī)療衛(wèi)生服務(wù)方、政府和社區(qū)合作,支持并促進(jìn)世界各地的人們能夠獲得更為可靠和可承付的醫(yī)療衛(wèi)生服務(wù)。這與輝瑞作為一家全球卓越的創(chuàng)新生物制藥公司的責(zé)任是一致的。170余年來(lái),輝瑞一直致力于為所有依賴我們的人帶來(lái)改變。輝瑞于1989年進(jìn)入中國(guó)市場(chǎng)。扎根中國(guó)30余年,輝瑞已成為在華主要的外資制藥公司之一。2021年是輝瑞新征程的開(kāi)始。迄今已有170余年歷史的輝瑞正在邁入全新時(shí)代,成為一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。目前輝瑞在中國(guó)業(yè)務(wù)覆蓋全國(guó)300余個(gè)城市,累計(jì)投資超過(guò)15億美元,并設(shè)立了1家先進(jìn)的生產(chǎn)設(shè)施,2個(gè)研發(fā)中心(分別位于上海張江高科技園區(qū)和武漢光谷),在華有近7,000名員工分布于業(yè)務(wù)、研發(fā)和生產(chǎn)等領(lǐng)域。輝瑞在華上市了五大領(lǐng)域的高品質(zhì)創(chuàng)新產(chǎn)品,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見(jiàn)病等多個(gè)領(lǐng)域的處方藥和疫苗,強(qiáng)大完善的產(chǎn)品線旨在滿足生命各階段的健康需求。
公司主頁(yè)